0000000000739825

AUTHOR

Arnaud Salmon-rousseau

showing 4 related works from this author

Myelitis and tenosynovitis attributed to toxocariasis

2019

medicine.medical_specialtyTenosynovitisRheumatologybusiness.industryTreatment outcomemedicineFollow up studiesToxocariasisMEDLINEMyelitismedicine.diseasebusinessDermatologyJoint Bone Spine
researchProduct

Prevalence and incidence of kidney diseases leading to hospital admission in people living with HIV in France: an observational nationwide study.

2019

ObjectivesTo describe hospitalisations for kidney disease (KD) among people living with HIV (PLHIV) in France and to identify the factors associated with such hospitalisations since data on the epidemiology of KD leading to hospitalisation are globally scarce.DesignObservational nationwide study using the French Programme de Médicalisation des Systèmes d’Information database.SettingFrance 2008–2013.ParticipantsAround 10 862 PLHIV out of a mean of 5 210 856 patients hospitalised each year. All hospital admissions with a main diagnosis code indicating KD (International Classification of Diseases, 10th revision codes, N00 to –N39) were collected.Main outcome measuresThe prevalence and incidenc…

AdultMalemedicine.medical_specialtyPediatricskidney diseasePopulation030232 urology & nephrology1842glomerular diseaseHIV InfectionsDiseaseacute renal failure03 medical and health sciences0302 clinical medicineAcquired immunodeficiency syndrome (AIDS)EpidemiologymedicinePrevalenceHumansCumulative incidence030212 general & internal medicine1506educationAgedRetrospective StudiesAged 80 and overeducation.field_of_studybusiness.industryhospitalisationIncidence (epidemiology)IncidenceResearchHIVGeneral MedicineMiddle Agedmedicine.diseaseHospitalizationHIV/AIDSObservational studyFemaleKidney DiseasesFrancebusinessKidney diseaseBMJ open
researchProduct

Myélite et ténosynovite attribuées à une toxocarose

2019

RheumatologyRevue du Rhumatisme
researchProduct

The usefulness of NEWS2 at day 7 of hospitalization in predicting COVID-19 evolution and as an early endpoint in therapeutic trials

2021

Highlights • There is a need for reliable tools to predict the evolution of hospitalized patients suffering from COVID-19 • The likelihood of unfavourable evolution for patients hospitalized for COVID-19 with a National • Early Warning Score 2 (NEWS2) below 7 at Day 7 of hospitalization is nearly non-existent • Such a score could thus be used to allow earlier discharge of the patients and as a judgement criterion in therapeutic trials

0301 basic medicineMicrobiology (medical)2019-20 coronavirus outbreakmedicine.medical_specialtyCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)030106 microbiologyNEWS2Communicable DiseasesArticle03 medical and health sciences0302 clinical medicineMedicineHumans030212 general & internal medicineIntensive care medicineUnfavourable eventAgedbusiness.industrySARS-CoV-2COVID-19Therapeutic trialCoronavirusHospitalizationInfectious DiseasesItalySARS-CoV2businessPredictionThe Journal of Infection
researchProduct